Cigarette Smoking Status at Diagnosis and Recurrence in Intermediate-risk Non-muscle-invasive Bladder Carcinoma Reply

被引：0
|
作者：
Serretta, Vincenzo [1 ]
机构：
[1] Univ Palermo, Urol Sect, Maternal Infant Androl & Urol Dept, Palermo, Italy
来源：
UROLOGY | 2013年 / 81卷 / 02期
关键词：
CANCER-DIAGNOSIS;
D O I：
10.1016/j.urology.2012.09.043
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 282
页数：2
相关论文
共 50 条
  • [41] Re: Hyperthermic Mitomycin C in Intermediate-Risk Non-Muscle-Invasive Bladder Cancer: Results of the HIVEC-1 Trial
    Chang, Sam S.
    JOURNAL OF UROLOGY, 2023, 210 (06): : 929 - 930
  • [42] THERAPEUTIC EFFECT OF MITOMYCIN C IN THE IMMEDIATE POSTOPERATIVE PERIOD IN PATIENTS WITH INTERMEDIATE-RISK NON-MUSCLE-INVASIVE BLADDER TUMORS.
    Jalon, Monzon A.
    Fernandez, Gomez J. M.
    Escaf, Barmadah S.
    Alvarez, Mugica M.
    Martin, Benito J. L.
    Regadera, Sejas F. J.
    ACTAS UROLOGICAS ESPANOLAS, 2008, 32 (09): : 894 - 903
  • [43] Photodynamic Diagnosis in Non-Muscle-Invasive Bladder Cancer
    Jichlinski, Patrice
    Jacqmin, Didier
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (07) : 529 - 535
  • [44] Fluid intake and recurrence and progression risk of patients with non-muscle-invasive bladder cancer
    Beeren, Ivy
    Meijer, Hilde
    van Der Heijden, Antoine G.
    Aben, Katja K. H.
    Witjes, J. Alfred
    Kiemeney, Lambertus A. L. M.
    Vrieling, Alina
    BJU INTERNATIONAL, 2025,
  • [45] The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
    Vrieling, Alina
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2018, 7 : S702 - S705
  • [46] Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Using EORTC Risk Tables
    Altieri, Vincenzo Maria
    Castellucci, Roberto
    Palumbo, Pietro
    Verratti, Vittore
    Sut, Michal
    Olivieri, Raffaella
    Manco, Rossella
    Ricciardulli, Stefano
    Nicolai, Michele
    Criniti, Pasquale
    Tenaglia, Raffaele Lanfranco
    UROLOGIA INTERNATIONALIS, 2012, 89 (01) : 61 - 66
  • [47] EXPECTANT MANAGEMENT FOR RECURRENT LOW RISK NON-MUSCLE-INVASIVE BLADDER CARCINOMA
    Hernandez Canas, V
    Alvarez, M.
    De La Pena, E.
    Amaruch, N.
    Martin, M. D.
    Capitan, C.
    De La Morena, J. M.
    Llorente, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 375 - 375
  • [48] OPTIMAL SUBCLASSIFICATION SYSTEM FOR INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER
    Matsumoto, Kazuhiro
    Kikuchi, Eiji
    Yanai, Yoshinori
    Hayakawa, Nozomi
    Niwa, Naoya
    Takahiro, Maeda
    Asanuma, Hiroshi
    Oya, Mototsugu
    JOURNAL OF UROLOGY, 2019, 201 (04): : E315 - E315
  • [49] The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study
    van Osch, Frits H. M.
    Jochems, Sylvia H. J.
    Reulen, Raoul C.
    Pirrie, Sarah J.
    Nekeman, Duncan
    Wesselius, Anke
    James, Nicholas D.
    Wallace, D. Michael A.
    Cheng, K. K.
    van Schooten, Frederik J.
    Bryan, Richard T.
    Zeegers, Maurice P.
    CANCER CAUSES & CONTROL, 2018, 29 (07) : 675 - 683
  • [50] The association between smoking cessation before and after diagnosis and non-muscle-invasive bladder cancer recurrence: a prospective cohort study
    Frits H. M. van Osch
    Sylvia H. J. Jochems
    Raoul C. Reulen
    Sarah J. Pirrie
    Duncan Nekeman
    Anke Wesselius
    Nicholas D. James
    D. Michael A. Wallace
    K. K. Cheng
    Frederik J. van Schooten
    Richard T. Bryan
    Maurice P. Zeegers
    Cancer Causes & Control, 2018, 29 : 675 - 683
12345